Phase 2 Study of a Temozolomide-Based Chemoradiation Therapy Regimen for High-Risk, Low-Grade Gliomas: Long-Term Results of Radiation Therapy Oncology Group 0424

Barbara J. Fisher, Stephanie L. Pugh, David Macdonald, Arnab Chakravatri, Glenn J. Lesser, Sherry Fox, Leland Rogers, Maria Werner‐Wasik, Thomas J. Doyle, Jean-Paul Bahary, John B. Fiveash, Joseph Bovi, Steven Howard, Ya-Yu Tsai, David D’Souza, Nadia N. Laack, Igor J. Barani, Young Kwok, Daniel Wahl, Jon F. Strasser, Minhee Won, Minesh P. Mehta